therapeutic advantage over the cisplatin-based regimen M-VAC (methotrexate, Concepcio Β΄n Almanza, M.D. vinblastine, doxorubicin, and cisplatin) in the treatment of patients with surgically Begon Λa Bermejo, M.D. incurable advanced bladder carcinoma. Luis-Alfonso Sole Β΄, M.D. ## METHODS. Patients w
Effective cisplatin (DDP) based chemotherapy in the treatment of hepatoblastoma
β Scribed by Douglass, Edwin C. ;Green, Alexander A. ;Wrenn, Earl ;Champion, John ;Shipp, Melissa ;Pratt, Charles B.
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- English
- Weight
- 294 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0098-1532
No coin nor oath required. For personal study only.
β¦ Synopsis
Nine of 11 patients with hepatoblastoma CR of pulmonary lesions. The average interval treated with cisplatin (DDP) based chemo-of disease control following DDP was three therapy had a complete (CR) or partial (PR) times that of Adriamycin (ADR). DDP is an remission. Five of these patients had measur-effective agent in the treatment of , able pulmonary disease and four achieved a hepatoblastoma.
π SIMILAR VOLUMES
## Background: Hepatoblastoma is an uncommon liver tumor of infancy and early childhood. though most patients with nonmetastatic hepatoblastomas can be cured by defining surgical strategies and chemotherapy regimes, new drugs are needed for children with advanced hepatoblastomas. the activity of pa
Nineteen patients, nine men and 10 women, with advanced adenoid cystic carcinoma (ACC), were treated with cisplatin either alone or in combination with doxorubicin and bleomycin. Median age was 51 years (range: 32-73 years). Two groups of patients were distinguished: Group 1 (N = 10) received single
Forty-three consecutive patients with metastatic breast cancer and clearly measurable disease were treated with sequential multiagent chemotherapy. Therapy consisted of the administration in fixed sequence of cisplatin, doxorubicin, and cyclophosphamide (PAC) (four cycles), vinbbtine, doxorubicin, a